Changes in SMC function may be impacted as a secondary consequence in PAH and HHT, though in the context of BMPR‐II mutations in PAH, reduced BMPR‐II in smooth muscle cells also promotes functional defects.53 The gene discussed is BMPR2; the disease is hereditary hemorrhagic telangiectasia.